Practical Course Alzheimer 2025
Practical Course Alzheimer 2025 December 12, 2025 Hilton Miami Dadeland – Miami, FL 9100 N Kendall Dr, Miami, FL 33176 The second edition of the Practical Course on Alzheimer’s takes […]
Alzheimer’s
Medicare to Restrict Coverage of Anti-Amyloid Antibody Therapy for Alzheimer’s Patients
By Jeffrey Gelblum, MD As a practicing neurologist with over 25 years of experience treating Alzheimer’s disease, I strongly oppose the proposed intention of Centers for Medicare & Medicaid Services
Medicare to Restrict Coverage of Anti-Amyloid Antibody Therapy for Alzheimer’s Patients Read More »
World Alzheimer’s Day: Alzheimer’s, Dementia, and the Brain
Today is World Alzheimer’s Day. It’s a day to celebrate to create awareness about the disease and to reduce the stigmatization and lack of information surrounding dementia. While World Alzheimer’s
World Alzheimer’s Day: Alzheimer’s, Dementia, and the Brain Read More »
Biogen Offering Free Alzheimer’s Drug Aduhelm to Patients
Biogen is providing its new Alzheimer’s drug, Aduhelm, free to some patients due to slow reviews by Medicare. There is a division among doctors about whether Aduhelm, also known as aducanumab,
Biogen Offering Free Alzheimer’s Drug Aduhelm to Patients Read More »
First Florida Patient to Receive Biogen Aducanumab Infusion
Jeff Gelblum, MD, a board-certified neurologist with First Choice Neurology, the nation’s largest neurology practice, is scheduled to treat the first patient in Florida with Biogen’s Aducanumab (Aduhelm), a monthly
First Florida Patient to Receive Biogen Aducanumab Infusion Read More »
Alzheimer’s Patients and Holiday Gatherings
The holidays can be a stressful time, especially for families of a loved one diagnosed with Alzheimer’s disease. When a family member has dementia or Alzheimer’s disease, the family dynamic
Biogen Seeks FDA Approval for New Alzheimer’s Drug
Biogen is planning to file for U.S. regulatory approval for its Alzheimer’s treatment aducanumab after data from more patients in two discontinued studies showed that the drug improved cognition at
Biogen Seeks FDA Approval for New Alzheimer’s Drug Read More »
June is Alzheimer’s and Brain Awareness Month
June is Alzheimer’s and Brain Awareness Month. Everyone who has a brain is at risk of developing Alzheimer’s disease (AD). There are 50 million people worldwide living with Alzheimer’s and